Asymchem | Briefing, News, Analysis, Research, Data

Asymchem

Asymchen combines molecular biology technology

Asymchen combines molecular biology technology, fermentation technology and process development technology to provide customers with carbapenems, cGMP APIs and other products used in anti-viral, anti-cancer, cardiovascular and cerebrovascular diseases, diabetes and other major diseases, and cooperates with Novartis, Bristol-Myers Squibb, AstraZeneca and GlaxoSmithKline.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Oct 1, 1998

HQ location

Tianjin, China

Legal name

Asymchem Laboratories (Tianjin) Co., Ltd.

Website

http://www.asymchem.com.cn

BDchina@asymchem.com.cn

Employees

1001-5000

All
News
Analysis
Research

Briefing Jun 24, 2022 10:39 AM · Technology | Healthcare | Industrials

The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan

Briefing Jun 13, 2022 10:14 AM · Technology | Consumer Staples | Communication

The private placement market is full of chaos, and the regulators' sword is intended to support the good and limit the bad

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Jun 13, 2022 09:44 AM · Healthcare

Cro plate fell, and Wuxi apptec fell nearly 10%

Briefing Jun 07, 2022 10:37 AM · Healthcare | Real Estate | Industrials

The port sector continued to strengthen and Guangzhou port rose by the daily limit

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 25, 2022 10:38 AM · Technology | Healthcare | Financials

"Zhongke spectral light" completed tens of millions of yuan of round a financing

Briefing Feb 20, 2022 04:29 PM · Consumer Staples | Healthcare | Financials

Sanhua intelligent control: Tesla's recall has nothing to do with the electronic expansion valve provided by the company

Briefing Feb 15, 2022 10:49 AM · Automotive | Technology | Communication

The whole vehicle sector rose in shock, and Shuguang shares closed the limit

Briefing Feb 11, 2022 06:09 PM · Technology | Healthcare | Real Estate

Shimao Group's contract sales in January were 7.51 billion yuan, up from 20 billion yuan in the same period last year.

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Feb 10, 2022 10:19 AM · Technology | Consumer Staples | Healthcare

Baby concept stock change

Briefing Feb 08, 2022 09:39 AM · Consumer Staples | Healthcare | Financials

The digital currency sector opened sharply lower

Briefing Jan 26, 2022 01:19 PM · Consumer Staples | Healthcare | Automotive

Kia's fourth quarter sales were 17.19 trillion won, lower than expected

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Jan 19, 2022 05:59 PM · Technology | Healthcare | Financials

Bohui shares: Shenzhen Stock Exchange resumed the examination of convertible bond issuance application

Briefing Dec 29, 2021 09:39 AM · Consumer Staples | Healthcare

The pharmaceutical and biological sector has been heavily sold off by the main funds in the past three days

Briefing Dec 17, 2021 09:49 AM · Technology | Healthcare | Financials

21 people trapped in the flooding accident of illegal mining coal mine in Shanxi: 9 suspects have controlled 7 people

Briefing Dec 13, 2021 01:40 PM · Consumer Staples | Communication | Healthcare

"Lingjing oasis" completed ten million yuan financing

EqualOcean Analysis